{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:54:28Z","timestamp":1793066068016,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009067","name":"K Albin Johansson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.labinv.2026.106134","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:21:38Z","timestamp":1778890898000},"page":"106134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cross-Platform Comparative Spatial Transcriptomics in High-Grade Serous Carcinoma"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1827-9156","authenticated-orcid":false,"given":"Omar","family":"Youssef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Selander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Csellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"H\u00e4nninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Carp\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Ray","family":"Laury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.labinv.2026.106134_bib1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41416-020-0763-4","article-title":"Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases","volume":"122","author":"Masoodi","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib2","article-title":"Immune cell landscapes are associated with high-grade serous ovarian cancer survival","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib3","article-title":"Effect of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.labinv.2026.106134_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/diagnostics10040200","article-title":"Intratumoral genomic heterogeneity may hinder precision medicine strategies in patients with serous ovarian carcinoma","volume":"10","author":"Nakamura","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.labinv.2026.106134_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/PAS.0000000000002187","article-title":"Morphologic and molecular heterogeneity of high-grade serous carcinoma precursor lesions","volume":"48","author":"Chien","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41698-018-0063-0","article-title":"Tumor evolution and chemoresistance in ovarian cancer","volume":"2","author":"Kim","year":"2018","journal-title":"NPJ Precis Oncol"},{"issue":"6","key":"10.1016\/j.labinv.2026.106134_bib7","article-title":"Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: implications for surgical and clinical outcomes","volume":"4","author":"Cunnea","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.labinv.2026.106134_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fonc.2015.00149","article-title":"Harnessing pandemonium: the clinical implications of tumor heterogeneity in ovarian cancer","volume":"5","author":"Blagden","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.labinv.2026.106134_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1420847","article-title":"Integrating single-cell and spatial transcriptomic analysis to unveil heterogeneity in high-grade serous ovarian cancer","volume":"15","author":"Luo","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12943-024-02040-9","article-title":"Advances in spatial transcriptomics and its applications in cancer research","volume":"23","author":"Jin","year":"2024","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib11","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","article-title":"Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response","volume":"14","author":"Arora","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","article-title":"Method of the year: spatially resolved transcriptomics","volume":"18","author":"Marx","year":"2021","journal-title":"Nat Methods"},{"issue":"9","key":"10.1016\/j.labinv.2026.106134_bib13","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.3390\/cancers12092572","article-title":"Transcriptional spatial profiling of cancer tissues in the era of immunotherapy: the potential and promise","volume":"12","author":"Nerurkar","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.labinv.2026.106134_bib14","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.molcel.2021.03.016","article-title":"Applicability of spatial transcriptional profiling to cancer research","volume":"81","author":"Bassiouni","year":"2021","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib15","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1038\/s41467-023-37806-0","article-title":"Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer","volume":"14","author":"Carter","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s12967-023-04395-x","article-title":"Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment","volume":"21","author":"Liu","year":"2023","journal-title":"J Transl Med"},{"issue":"Suppl 2","key":"10.1016\/j.labinv.2026.106134_bib17","article-title":"151 Using additional morphology markers in NanoString\u00ae GeoMx\u00ae whole transcriptome atlas assay to assess NSCLC tumor subtype","volume":"10","author":"Runyon","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib18","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1038\/s41467-021-26271-2","article-title":"Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions","volume":"12","author":"Andersson","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.labinv.2026.106134_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113752","article-title":"Integrating scRNA-seq and Visium HD for the analysis of the tumor microenvironment in the progression of colorectal cancer","volume":"145","author":"Wang","year":"2025","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.labinv.2026.106134_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108429","article-title":"Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer","volume":"26","author":"Quan","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib21","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41467-024-47271-y","article-title":"Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones","volume":"15","author":"Denisenko","year":"2024","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.labinv.2026.106134_bib22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/0008-5472.CAN-22-1821","article-title":"Spatial transcriptomics depict ligand\u2013receptor cross-talk heterogeneity at the tumor-stroma interface in long-term ovarian cancer survivors","volume":"83","author":"Ferri-Borgogno","year":"2023","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.labinv.2026.106134_bib23","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-22-1620","article-title":"Spatial transcriptomic analysis of ovarian cancer precursors reveals reactivation of IGFBP2 during pathogenesis","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.labinv.2026.106134_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103923","article-title":"Spatially resolved transcriptomics of high-grade serous ovarian carcinoma","volume":"25","author":"Stur","year":"2022","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.labinv.2026.106134_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100508","article-title":"Opening the black box: spatial transcriptomics and the relevance of artificial intelligence\u2013detected prognostic regions in high-grade serous carcinoma","volume":"37","author":"Laury","year":"2024","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98480-0","article-title":"Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone","volume":"11","author":"Laury","year":"2021","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.labinv.2026.106134_bib27","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41467-022-28020-5","article-title":"Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data","volume":"13","author":"Danaher","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.labinv.2026.106134_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm1831","article-title":"Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci Adv"},{"issue":"6","key":"10.1016\/j.labinv.2026.106134_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.labinv.2026.106134_bib32","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.labinv.2026.106134_bib33","article-title":"GeoMx DSP NGS readout user manual","year":"2022","journal-title":"NanoString Technologies"},{"key":"10.1016\/j.labinv.2026.106134_bib35","article-title":"An experimental comparison of the Digital Spatial Profiling and Visium spatial transcriptomics technologies for cancer research","author":"Wang","year":"2023","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.labinv.2026.106134_bib36","article-title":"Caution towards spurious off-target signal in 10X Visium spatial transcriptomics assay from potential lncRNAs","volume":"24","author":"Prakrithi","year":"2023","journal-title":"Brief Bioinform"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105760","article-title":"Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data","volume":"26","author":"van Hijfte","year":"2022","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.labinv.2026.106134_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/biostatistics\/kxw055","article-title":"Overcoming confounding plate effects in differential expression analyses of single-cell RNA-seq data","volume":"18","author":"Lun","year":"2017","journal-title":"Biostatistics"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib39","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1038\/s41467-021-25960-2","article-title":"Confronting false discoveries in single-cell differential expression","volume":"12","author":"Squair","year":"2021","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.labinv.2026.106134_bib40","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.3390\/cancers14246068","article-title":"Platinum-resistant ovarian cancer is vulnerable to the cJUN-XRCC4 pathway inhibition","volume":"14","author":"Xu","year":"2022","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.labinv.2026.106134_bib41","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1158\/1078-0432.CCR-19-3790","article-title":"DGKA provides platinum resistance in ovarian cancer through activation of c-JUN-WEE1 signaling","volume":"26","author":"Li","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.labinv.2026.106134_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.500","article-title":"Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma","volume":"11","author":"Hao","year":"2021","journal-title":"Clin Transl Med"},{"issue":"10","key":"10.1016\/j.labinv.2026.106134_bib43","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00432-013-1489-y","article-title":"The prognostic significance of Jun transcription factors in ovarian cancer","volume":"139","author":"Eckhoff","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.labinv.2026.106134_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/kjm2.12467","article-title":"LINC01224 facilitates the proliferation and inhibits the radiosensitivity of melanoma cells through the miR-193a-5p\/NR1D2 axis","volume":"38","author":"Cui","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"issue":"24","key":"10.1016\/j.labinv.2026.106134_bib45","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1038\/s44318-024-00290-3","article-title":"Nuclear receptor E75\/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways","volume":"43","author":"Wang","year":"2024","journal-title":"EMBO J"},{"key":"10.1016\/j.labinv.2026.106134_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1208132","article-title":"Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer","volume":"10","author":"Zhao","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"3","key":"10.1016\/j.labinv.2026.106134_bib47","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41591-021-01244-6","article-title":"Transcriptional mediators of treatment resistance in lethal prostate cancer","volume":"27","author":"He","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.labinv.2026.106134_bib48","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-23-0700","article-title":"TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes antitumor immunity","volume":"14","author":"Tani","year":"2024","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.labinv.2026.106134_bib49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1158\/2326-6066.CIR-23-1093","article-title":"Intratumoral TREX1 induction promotes immune evasion by limiting type I IFN","volume":"12","author":"Toufektchan","year":"2024","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"10.1016\/j.labinv.2026.106134_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13402-014-0174-8","article-title":"Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report","volume":"37","author":"Momeni","year":"2014","journal-title":"Cell Oncol (Dordr)"},{"issue":"47","key":"10.1016\/j.labinv.2026.106134_bib51","doi-asserted-by":"crossref","first-page":"28532","DOI":"10.18632\/oncotarget.25536","article-title":"Prostate cancer susceptibility gene HIST1H1A is a modulator of androgen receptor signaling and epithelial to mesenchymal transition","volume":"9","author":"Williams","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.labinv.2026.106134_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2741\/3934","article-title":"Profiling of linker histone variants in ovarian cancer","volume":"17","author":"Medrzycki","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib53","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1038\/s41467-025-59005-9","article-title":"Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity","volume":"16","author":"Dong","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.labinv.2026.106134_bib54","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1038\/s41467-025-64292-3","article-title":"Systematic benchmarking of high-throughput subcellular spatial transcriptomics platforms across human tumors","volume":"16","author":"Ren","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.labinv.2026.106134_bib55","article-title":"Benchmarking of spatial transcriptomics platforms across six cancer types","author":"Cervilla","year":"2025","journal-title":"bioRxiv"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:33:35Z","timestamp":1784028815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683726000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0023683726000644"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106134","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-Platform Comparative Spatial Transcriptomics in High-Grade Serous Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"106134"}}